EP3426251
Aðferðir af meðhöndlun geðdeyfð með því að nota órexín-2 viðtakamótverkendur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.3.2017EP published:
20.4.2022EP application number:
17764092.7
EP translation filed:
24.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
8.3.2037Expiry date:
8.3.2027Next due date:
31.3.2027
Title in English:
METHODS OF TREATING DEPRESSION USING OREXIN-2 RECEPTOR ANTAGONISTSLanguage of the patent:
English
Timeline
Today
9.3.2017EP application
20.4.2022EP Publication
24.5.2022Translation submitted
15.6.2022Registration published
8.3.2027Expires
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
KENT, Justine, M.Address:
Titusville,NJ 08560, US
Name:
DREVETS, Wayne, C.Address:
Titusville,NJ 08560, US
Name:
DE BOER, PeterAddress:
B-2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662306487 PDate:
10.3.2016Country:
US
Classification
Categories:
A61K 45/06, A61K 9/00, A61K 9/10, A61K 47/38, A61K 9/20, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.2.2023
Expires: 8.3.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.2.2024
Expires: 8.3.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.2.2025
Expires: 8.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.3.2026
Expires: 8.3.2027
Payer: Árnason Faktor ehf.